Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder

Stopped early · Not applicable

Conditions studied: Opioid-use Disorder

In brief

In this pilot single-armed open-label intervention study of up to 20 individuals with moderate to severe Opioid Use Disorder (OUD)organized into two consecutive groups of up to 10 individuals each, the investigators will measure addiction outcomes and the acceptability and feasibility of adding Mindfulness Oriented Recovery Enhancement (MORE), a promising mind-body therapy to gold standard in-hospital addiction consultation among hospitalized individuals with OUD in advance of a planned two-arm pilot randomized controlled trial.

Key facts

Study ID

NCT05066321

Run by

Massachusetts General Hospital

People needed

20

Starts

2022-03-18

Expected to finish

2023-09-01

Last updated by the study team

2024-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must be 18 years old and older
• English-speaking
• Hospitalized at Massachusetts General Hospital, being evaluated by the Addiction Consult Team
• Meet DSM-5 criteria for moderate or severe OUD as documented by Addiction Consult Team

You may not qualify if…

• Individuals currently admitted to an Intensive Care Unit
• Individuals who are in legal custody or will not be discharged from a controlled environment during the study period
• Inability to provide informed consent as assessed by the medical team
• Active COVID-19 infection

Where it is running

• Division of General Internal Medicine — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.